MedTrace Logo

Medication Intake of Solid Dosage Forms: A Risk Factor for Patients With Stroke-induced Dysphagia?

NCT05173051 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2024-03-06

No results posted yet for this study

Summary

In a prospective, quantitative explorative study, the risk of aspiration and penetration when swallowing solid pills (placebo) compared to a crushed placebo pill will be evaluated during a routine Fiberoptic Endoscopic Evaluation of Swallowing (FEES). The study design is thus a quasi-experimental study design with repeated measurements in the sense of a pre-posttest. Each patient undergoes a baseline examination (routine procedure) followed by the intervention (administration of three different solid pills and a crushed pill).

Conditions

Interventions

OTHER

Solid Medication intake vs. crushed medication intake

The swallowing ability for solid and crushed medications in stroke patients is evaluated.

Sponsors & Collaborators

  • Paracelsus Medical University

    collaborator OTHER

  • Karl Landsteiner University of Health Sciences

    lead OTHER

Principal Investigators

  • Walter Struhal, Prof. Dr · University Clinic Tulln

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
50 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-02-01
Primary Completion
2023-12-07
Completion
2023-12-07

Countries

  • Austria

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05173051 on ClinicalTrials.gov